UroGen PharmaURGN 
$11.30-0.44%24h
-0.44%24h
Global rank2952
Market cap$348.79M
Change 7d-6.92%
YTD Performance-24.52%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of UroGen Pharma (URGN)
As of December 2024, UroGen Pharma has a market cap of $348.79M. This makes UroGen Pharma the world's 2952th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of UroGen Pharma from 2017 to 2024
-
Value:-
Market cap history of UroGen Pharma from 2017 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $585.53M | 26.47% |
| 2023 | $462.99M | 69.11% |
| 2022 | $273.78M | -6.73% |
| 2021 | $293.54M | -47.23% |
| 2020 | $556.21M | -46.00% |
| 2019 | $1.03B | -22.50% |
| 2018 | $1.33B | 15.72% |
| 2017 | $1.15B | - |
URGN Market Cap Today is $348.79M -0.44% - 17 Dec 2024
View largest stocks by market cap 
